Company / Current Assets
Day One Biopharmaceuticals, Inc. Current Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$485.1M
FY2025
5-year range
$289.4M / $562.3M
FY2021-FY2025
Trend
-13.7%
vs FY2024
Sector context
#121 of 215
Health Care
What the data says
At $485M, Day One Biopharmaceuticals, Inc.'s current assets ranks #121 of 215 in the Health Care sector. Improved from $375M to $485M over the past 2 years.
Based on SEC 10-K filings.
$485M in FY2025 with a 5-year CAGR of +60.8%.
Improved from $375M to $485M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +11.7%
- 5-Year CAGR
- +60.8%
- 10-Year CAGR
- -
Sector benchmark
#121 of 215 in Health CareTop 56% of 215This company $485.1M Sector average $2.5B
▼
-80.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +60.8%, indicating consistent growth.
- In FY2025, current assets decreased 13.7% year-over-year.
- Ranks #121 out of 215 companies in the Health Care sector.
- Peak current assets was recorded in FY2024.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $485.1M | -13.7% |
| FY2024 | $562.3M | +49.8% |
| FY2023 | $375.3M | +7.9% |
| FY2022 | $347.9M | +20.2% |
| FY2021 | $289.4M | +542.0% |
| FY2020 | $45.1M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026